protein

OGN/Osteoglycin Protein, Mouse (HEK293, His)

HY-P702525

2 μg;10 μg;50 μg;100 μg

38;108;300;480 USD

OGN/Osteoglycin Protein, Mouse (HEK293, His)

proteins

HEK293

2 μg;10 μg;50 μg;100 μg

38;108;300;480 USD

OGN/Osteoglycin protein collaborates with TGF-beta-1 or TGF-beta-2 to regulate bone formation. It interacts synergistically with specific isoforms of TGF-beta, modulating bone development and remodeling. This highlights OGN's significance in bone homeostasis and its potential as a therapeutic target for bone-related conditions. OGN/Osteoglycin Protein, Mouse (HEK293, His) is the recombinant mouse-derived OGN/Osteoglycin protein, expressed by HEK293 , with C-6*His labeled tag. The total length of OGN/Osteoglycin Protein, Mouse (HEK293, His) is 279 a.a.

Mouse

OGN/Osteoglycin protein acts as a key regulator, inducing bone formation in collaboration with TGF-beta-1 or TGF-beta-2. This implies that OGN plays a pivotal role in modulating bone development and remodeling processes by synergistically interacting with specific isoforms of transforming growth factor-beta. The orchestrated interplay between OGN and TGF-beta signaling pathways underscores its significance in the intricate molecular mechanisms governing bone homeostasis and highlights its potential as a therapeutic target for conditions related to bone formation and maintenance.

Mimecan; DKFZp586P2421; KSPG25; mimecan proteoglycan; Mimecan; OGN; OIF; OIFOG; osteoglycin; Osteoinductive factor; SLRR3A; SLRR3Acorneal keratan sulfate proteoglycan

Greater than 95% as determined by reducing SDS-PAGE.

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.

Room temperature in continental US; may vary elsewhere.